111 related articles for article (PubMed ID: 22733650)
21. A new method for modeling preoperative diagnosis of ovarian tumors.
Stalbovskaya V; Ifeachor EC; Van Huffel S; Timmerman D
IEEE Trans Biomed Eng; 2007 Nov; 54(11):2064-72. PubMed ID: 18018702
[TBL] [Abstract][Full Text] [Related]
22. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
23. Polychotomization of continuous variables in regression models based on the overall C index.
Tsuruta H; Bax L
BMC Med Inform Decis Mak; 2006 Dec; 6():41. PubMed ID: 17169154
[TBL] [Abstract][Full Text] [Related]
24. Significance analysis of ROC indices for comparing diagnostic markers: applications to gene microarray data.
Tsai CA; Chen JJ
J Biopharm Stat; 2004 Nov; 14(4):985-1003. PubMed ID: 15587976
[TBL] [Abstract][Full Text] [Related]
25. External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery.
Chereau E; Lavoue V; Ballester M; Coutant C; Selle F; Cortez A; Daraï E; Leveque J; Rouzier R
Anticancer Res; 2011 Dec; 31(12):4469-74. PubMed ID: 22199317
[TBL] [Abstract][Full Text] [Related]
26. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
[TBL] [Abstract][Full Text] [Related]
27. Evaluating prediction models in reproductive medicine.
Coppus SF; van der Veen F; Opmeer BC; Mol BW; Bossuyt PM
Hum Reprod; 2009 Aug; 24(8):1774-8. PubMed ID: 19395365
[TBL] [Abstract][Full Text] [Related]
28. Marker selection via maximizing the partial area under the ROC curve of linear risk scores.
Wang Z; Chang YC
Biostatistics; 2011 Apr; 12(2):369-85. PubMed ID: 20729218
[TBL] [Abstract][Full Text] [Related]
29. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Köbel M; Kalloger SE; Carrick J; Huntsman D; Asad H; Oliva E; Ewanowich CA; Soslow RA; Gilks CB
Am J Surg Pathol; 2009 Jan; 33(1):14-21. PubMed ID: 18830127
[TBL] [Abstract][Full Text] [Related]
30. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.
Pencina MJ; D'Agostino RB
Stat Med; 2004 Jul; 23(13):2109-23. PubMed ID: 15211606
[TBL] [Abstract][Full Text] [Related]
31. The partial area under the summary ROC curve.
Walter SD
Stat Med; 2005 Jul; 24(13):2025-40. PubMed ID: 15900606
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models.
Mol BW; Boll D; De Kanter M; Heintz AP; Sijmons EA; Oei SG; Bal H; Brölmann HA
Gynecol Oncol; 2001 Feb; 80(2):162-7. PubMed ID: 11161854
[TBL] [Abstract][Full Text] [Related]
33. Extending the skill test for disease diagnosis.
Lin SC; Kvam PH; Lu JC
Stat Med; 2009 Feb; 28(5):798-813. PubMed ID: 19072748
[TBL] [Abstract][Full Text] [Related]
34. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
35. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores.
Paul M; Raz A; Leibovici L; Madar H; Holinger R; Rubinovitch B
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):397-403. PubMed ID: 17258572
[TBL] [Abstract][Full Text] [Related]
36. Caution when using prognostic models: a prospective comparison of 3 recent prognostic models.
Nassar AP; Mocelin AO; Nunes AL; Giannini FP; Brauer L; Andrade FM; Dias CA
J Crit Care; 2012 Aug; 27(4):423.e1-7. PubMed ID: 22033059
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk assessment of pulmonary embolism with the GRACE risk score.
Paiva LV; Providencia RC; Barra SN; Faustino AC; Botelho AM; Marques AL
Am J Cardiol; 2013 Feb; 111(3):425-31. PubMed ID: 23168283
[TBL] [Abstract][Full Text] [Related]
38. Use and misuse of the receiver operating characteristic curve in risk prediction.
Cook NR
Circulation; 2007 Feb; 115(7):928-35. PubMed ID: 17309939
[TBL] [Abstract][Full Text] [Related]
39. A measure of association for assessing prediction accuracy that is a generalization of non-parametric ROC area.
Smith WD; Dutton RC; Smith NT
Stat Med; 1996 Jun; 15(11):1199-215. PubMed ID: 8804148
[TBL] [Abstract][Full Text] [Related]
40. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms.
McGregor JC; Kim PW; Perencevich EN; Bradham DD; Furuno JP; Kaye KS; Fink JC; Langenberg P; Roghmann MC; Harris AD
Am J Epidemiol; 2005 Mar; 161(5):483-93. PubMed ID: 15718484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
